Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $5.95 Million - $7.39 Million
7,700 New
7,700 $6.82 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $3.82 Million - $4.36 Million
12,900 New
12,900 $4.17 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $41.1 Million - $51 Million
-175,000 Reduced 87.5%
25,000 $7.16 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $36.9 Million - $45.5 Million
166,700 Added 500.6%
200,000 $46.2 Million
Q1 2021

May 17, 2021

BUY
$164.32 - $212.72 $5.23 Million - $6.76 Million
31,800 Added 2120.0%
33,300 $6.22 Million
Q3 2020

Nov 09, 2020

SELL
$146.22 - $169.13 $5.26 Million - $6.09 Million
-36,000 Reduced 96.0%
1,500 $222,000
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $3.81 Million - $4.58 Million
27,900 Added 290.63%
37,500 $6.16 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $1.14 Million - $1.41 Million
9,600 New
9,600 $1.33 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.